Screening compound: InChI=1S/C19H28N6/c1-3-9-23(10-4-1)15-7-12-24(13-8-15)18-17-19(21-14-20-18)25-11-5-2-6-16(25)22-17/h14-15H,1-13H2

Screening compound: InChI=1S/C19H28N6/c1-3-9-23(10-4-1)15-7-12-24(13-8-15)18-17-19(21-14-20-18)25-11-5-2-6-16(25)22-17/h14-15H,1-13H2
Screening compound: InChI=1S/C19H28N6/c1-3-9-23(10-4-1)15-7-12-24(13-8-15)18-17-19(21-14-20-18)25-11-5-2-6-16(25)22-17/h14-15H,1-13H2 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C19H28N6/c1-3-9-23(10-4-1)15-7-12-24(13-8-15)18-17-19(21-14-20-18)25-11-5-2-6-16(25)22-17/h14-15H,1-13H2

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E715-1056

Molecular Formula

C19H28N6 (C19 H28 N6)

Compound Name

1'-{6H,7H,8H,9H-pyrido[2,1-h]purin-4-yl}-1,4'-bipiperidine

IUPAC name

1'-{6H7H8H9H-pyrido[21-h]purin-4-yl}-14'-bipiperidine

SMILES

C(CC1)CCN1C(CC1)CCN1c1ncnc2c1nc1n2CCCC1

MDL Number (MFCD)

InChI=1S/C19H28N6/c1-3-9-23(10-4-1)15-7-12-24(13-8-15)18-17-19(21-14-20-18)25-11-5-2-6-16(25)22-17/h14-15H,1-13H2 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS BBB Library (22607 compounds)

GPCR Targeted Library (31838 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Protein-Protein Interaction Library (218420 compounds)

Akt-Targeted Library (14764 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

New Agro Library (44492 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Kinases
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
Structure:
  • Cyclic compounds
Agro:
  • Agro

References: we are preparing a list of scientific research reports with InChI=1S/C19H28N6/c1-3-9-23(10-4-1)15-7-12-24(13-8-15)18-17-19(21-14-20-18)25-11-5-2-6-16(25)22-17/h14-15H,1-13H2 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C19H28N6/c1-3-9-23(10-4-1)15-7-12-24(13-8-15)18-17-19(21-14-20-18)25-11-5-2-6-16(25)22-17/h14-15H,1-13H2?
Check Price and Availability of InChI=1S/C19H28N6/c1-3-9-23(10-4-1)15-7-12-24(13-8-15)18-17-19(21-14-20-18)25-11-5-2-6-16(25)22-17/h14-15H,1-13H2, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C19H28N6/c1-3-9-23(10-4-1)15-7-12-24(13-8-15)18-17-19(21-14-20-18)25-11-5-2-6-16(25)22-17/h14-15H,1-13H2 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C19H28N6/c1-3-9-23(10-4-1)15-7-12-24(13-8-15)18-17-19(21-14-20-18)25-11-5-2-6-16(25)22-17/h14-15H,1-13H2
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C19H28N6/c1-3-9-23(10-4-1)15-7-12-24(13-8-15)18-17-19(21-14-20-18)25-11-5-2-6-16(25)22-17/h14-15H,1-13H2
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C19H28N6/c1-3-9-23(10-4-1)15-7-12-24(13-8-15)18-17-19(21-14-20-18)25-11-5-2-6-16(25)22-17/h14-15H,1-13H2 available by request